Skip to content
Explore writing techniques, storytelling advice, and creati…

The Zimbabwean Government Turns Down ‘Unbalanced’ American Healthcare Assistance Deal Because of Information Fears

Medical aid image
The offered US financial assistance was aimed at programmes for HIV/Aids treatment and prevention, TB, and malaria.

The nation of Zimbabwe has declined a major US health deal worth $367m (272 million pounds) over five years because of Washington's insistence on confidential information.

This move came to light after a internal memorandum dated December was leaked, indicating that President Emmerson Mnangagwa deemed the deal was "lopsided".

An official representative later clarified that the United States was demanding access to biological samples for research and commercial purposes but was not willing to share the resulting advantages from any future treatments.

"We are forced to start the difficult and regrettable task of scaling back our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy said the US had provided over $1.9bn in health funding to Zimbabwe during the past twenty years.

A medical body in Zimbabwe has called for further dialogue to find a deal suitable to all parties so the nation's critical HIV treatment initiative can continue.

Wider Background

Zimbabwe's decision follows a similar situation in Kenya, where a court halted a similar deal with the US after concerns were filed about the safety of Kenyans' health data.

After resuming the presidency recently, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).

USAID had administered aid for the American government, but Trump claimed its expenditure was "inefficient" and his administration was seeking government-to-government deals to boost openness and responsibility.

According to reports, Sixteen African countries have to date signed similar agreements, representing more than $18.3bn in committed funds.

Details of the Declined Deal

This assistance for Zimbabwe was intended to supported "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.

"We believe this collaboration would have delivered significant advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving antiretroviral therapy through American-funded initiatives," the Ambassador added.

However, official spokesman Nick Mangwana argued the arrangement was "asymmetrical".

"Our nation was requested to share its genetic material and health information for a long time, without any corresponding assurance of access to any medical innovations – like vaccines, diagnostics, or treatments – that might be developed from that shared data," Mangwana explained.

"Effectively, our country would supply the basic resources for scientific discovery without any assurance that the final treatments would be accessible to our citizens should a future pandemic emerge."

National Interest and International Frameworks

He also pointed out that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were disrupting frameworks already set up through the international organization.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme created to manage potential pandemics.

"This system is designed to guarantee that when a country provides its samples, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the resources to develop them."

Zimbabwe's reservations over the US deal "should not be misconstrued as opposition to America," Mangwana stressed.

"We welcome continued dialogue with our American counterparts on how future co-operation might be structured in a manner that honours the sovereignty and interests of each country."

Medical Community Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the government's concerns, but suggested that negotiations need to persist since much of the nation's HIV programmes relied on foreign aid.

"In cases where technical issues exist, including those involving information security or agreement terms, these can often be resolved through technical clarification and mutually agreed protections," it said.

The situation emphasises the complex challenges between receiving much-needed foreign assistance and safeguarding a country's data in an increasingly data-driven world.

The writer

Debra Vega

A published novelist and writing coach who specializes in contemporary fiction and character development techniques.

BrightlyNotes

Type to search articles.